September 2024

NEUROSCIENCES

HIGHLIGHTS IN BRAIN CANCER RESEARCH FROM THE 2024 ASCO ANNUAL MEETING

In a recent episode of OncLive On Air, Northwestern Medicine Neuro-Oncologist Rimas Lukas, MD, discusses four key abstracts presented at the brain cancer­-focused clinical science symposium during the 2024 ASCO Annual Meeting.
 
He highlights:
  • Findings on ST101 in window-of-opportunity cohorts of patients with recurrent glioblastoma
  • The prognostic utility of cerebrospinal fluid circulating tumor DNA in recurrent high-grade glioma
  • The genomic drivers of glioblastoma
  • Preclinical data with navtemadlin (KRT-232) in IDH wild-type glioblastoma
 
Hear Dr. Lukas’ overview >
Rimas V Lukas, MD, associate professor of, Neuro-oncology, and Hospital Neurology at Northwestern Medicine

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like